Skip to main content

Table 1 KEGG Pathways generated by STRING

From: Salmonella enterica Typhimurium infection causes metabolic changes in chicken muscle involving AMPK, fatty acid and insulin/mTOR signaling

  

24 h

96 h

1 week

3 weeks

Pathway ID

Pathway name

# Peptides

p-value (FDR)

# Peptides

p-value (FDR)

# Peptides

p-value (FDR)

# Peptides

p-value (FDR)

hsa05221

Acute myeloid leukemia

4

0.0227

3

0.0344

2

0.228

3

0.0785

hsa04520

Adherens junction

4

0.0506

2

0.340

2

0.332

4

0.0302

hsa04920

Adipocytokine signaling pathway

6

0.0023

 

N/S

4

0.0131

7

0.0003

hsa04360

Axon guidance

6

0.0191

4

0.0432

 

N/S

 

N/S

hsa04662

B cell receptor signaling pathway

5

0.0123

3

0.0559

 

N/S

4

0.0297

hsa04020

Calcium signaling pathway

5

0.166

 

N/S

6

0.0095

 

N/S

hsa04062

Chemokine signaling pathway

4

0.469

5

0.0344

4

0.126

 

N/S

hsa05220

Chronic myeloid leukemia

4

0.0452

4

0.0103

2

0. 318

6

0.0012

hsa05210

Colorectal cancer

 

N/S

4

0.0066

 

N/S

3

0.0969

hsa05213

Endometrial cancer

3

0.0976

4

0.0047

 

N/S

 

N/S

hsa04012

ErbB signaling pathway

8

0.0001

7

0.0000

4

0.0167

5

0.0097

hsa04664

Fc epsilon RI signaling pathway

7

0.0006

5

0.0029

 

N/S

6

0.0018

hsa04666

Fc gamma R-mediated phagocytosis

4

0.0979

4

0.0224

 

N/S

5

0.0148

hsa04510

Focal adhesion

8

0.0123

6

0.0115

 

N/S

7

0.0154

hsa05214

Glioma

7

0.0001

3

0.0432

6

0.0001

5

0.0033

hsa00010

Glycolysis/Gluconeogenesis

5

0.0064

3

0.0432

3

0.0586

6

0.0008

hsa04912

GnRH signaling pathway

7

0.0015

5

0.0047

4

0.0245

5

0.0151

hsa05410

Hypertrophic cardiomyopathy (HCM)

3

0.264

 

N/S

3

0.106

6

0.0018

hsa04910

Insulin signaling pathway

13

0.0000

10

0.0000

7

0.0003

16

0.0000

hsa04730

Long-term depression

4

0.0449

3

0.0537

4

0.0113

 

N/S

hsa04010

MAPK signaling pathway

14

0.0001

13

0.0000

4

0.318

11

0.0011

hsa05218

Melanoma

4

0.0443

4

0.0095

4

0.0113

5

0.0043

hsa04150

mTOR signaling pathway

6

0.0004

3

0.0309

 

N/S

5

0.0018

hsa04722

Neurotrophin signaling pathway

6

0.0176

6

0.0020

5

0.0113

7

0.0018

hsa05223

Non-small cell lung cancer

5

0.0048

3

0.0362

 

N/S

4

0.0151

hsa05212

Pancreatic cancer

4

0.0418

3

0.0476

 

N/S

4

0.0227

hsa05200

Pathways in cancer

 

N/S

 

N/S

6

0.0639

9

0.0151

hsa04914

Progesterone-mediated oocyte maturation

5

0.0176

 

N/S

 

N/S

5

0.0097

hsa05215

Prostate cancer

5

0.0192

4

0.0173

4

0.0169

5

0.0107

hsa04810

Regulation of actin cytoskeleton

6

0.104

6

0.0115

 

N/S

6

0.0591

hsa05211

Renal cell carcinoma

4

0.0446

5

0.0018

 

N/S

4

0.0254

hsa05222

Small cell lung cancer

 

N/S

 

N/S

2

0.397

6

0.0020

hsa04660

T cell receptor signaling pathway

6

0.0123

4

0.0344

 

N/S

3

0.332

hsa04620

Toll-like receptor signaling pathway

5

0.0403

5

0.0058

 

N/S

6

0.0043

hsa04270

Vascular smooth muscle contraction

5

0.0452

3

0.139

 

N/S

4

0.105

hsa04370

VEGF signaling pathway

6

0.0023

 

N/S

 

N/S

4

0.0302

  1. Peptides that displayed a statistically significant change in phosphorylation state were input into the STRING database for each time point. Generated pathways that displayed a p-value of less than 0.05 (FDR corrected) are listed. Pathways that displayed statistical significance at three or more time points are shown in bold. N/S indicates that the pathway is Non-significant as no peptides were found within the pathway.